DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
M••••••
Healthcare & Pharmaceuticalsgroup grade Bon a schedule nowsponsor unattributed
What matters now
- $1.46Mprincipal outstanding
$1.46M principal held by 1 lender; matures May 2028.
Q1 2026 · Refinancing is due in 20 months at a 100¢ mark.
FactBDC schedules of investments, 31 Mar 2026; a sum of the BDCs' pieces, a lower bound
Mark path, consensus per quarter end
100¢ · 101¢ · 101¢ · 101¢ · 100¢Q1 2025 to Q1 2026
Principal held
at least $1.5M
sum of BDC pieces, a lower bound
Fair value
$1.5M
100c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
May 10, 2028
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Mar 31, 2026
Events
1
dated, non-routine
Lender marks
each lender's own fair value over cost at Mar 31, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| A•••• C••••• B•• I••• | $1.46M | 100¢ | -1 pts |
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• C••••• B•• I••• | term loan first lien Investment T••• S••••• S•••••• 2025 T••• L••• (F•••• L•••) I•••• S+ S••••• 3.00% I••••••• | $1.5M | $1.5M 100c | SOFR+300 bp |
Capital structure as the BDCs see it
latest quarter end Mar 31, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Mar 31, 2026 | at least $1.5M | 100c | SOFR+300 bp | May 10, 2028 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Mar 31, 2026 | 1 | $1.5M | $1.5M | 100c | 0 |
| Dec 31, 2025 | 1 | $1.5M | $1.5M | 101c | 0 |
| Sep 30, 2025 | 1 | $1.5M | $1.5M | 101c | 0 |
| Jun 30, 2025 | 1 | $1.5M | $1.5M | 101c | 0 |
All 13 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Mar 31, 2025 | 1 | $1.5M | $1.5M | 100c | 0 |
| Dec 31, 2024 | 1 | $3.0M | $3.0M | 101c | 0 |
| Sep 30, 2024 | 1 | $1.5M | $1.5M | 100c | 0 |
| Jun 30, 2024 | 1 | $486,250 | $488,227 | 101c | 0 |
| Mar 31, 2024 | 1 | $487,500 | $487,364 | 101c | 0 |
| Dec 31, 2023 | 1 | $977,500 | $972,964 | 100c | 0 |
| Sep 30, 2023 | 1 | $490,000 | $487,893 | 100c | 0 |
| Jun 30, 2023 | 1 | $491,250 | $481,015 | 99c | 0 |
| Dec 31, 2022 | 1 | $493,750 | $467,334 | 95c | 0 |
What changed
- Facility left every BDC scheduleMar 31, 2026
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- MEDRISKderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it